Pentamidine reduces expression of hypoxia-inducible factor-1α in DU145 and MDA-MB-231 cancer cells.

doi:10.1016/j.canlet.2011.01.008

Paper

Pentamidine reduces expression of hypoxia-inducible factor-1α in DU145 and MDA-MB-231 cancer cells.

Published Apr 1, 2011 · Hui-Jung Jung, S. Suh, M. Suh

Cancer letters

Q1 SJR score

24

Citations

1

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro Study

Study Snapshot

Pentamidine shows potential as an inhibitor of hypoxia-inducible factor-1 in cancer cells, suggesting its potential as a cancer therapeutic reagent.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Pentamidine reduces expression of hypoxia-inducible factor-1α in DU145 and MDA-MB-231 cancer cells.

References

Citations